ENTX Competitors & Alternatives
Compare Entera Bio Ltd with similar stocks in the same industry
Biotechnology
ENTX
Main Stock$2.92
Tradestie Score
43
Market Cap
$84.52M
Revenue Growth
-1.0%
Analyst Upside
+233.9%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$2.32
|
$552.46M | - | 53 | Compare |
|
VSTM
Verastem, Inc.
|
$10.04
|
$541.60M | - | 39 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.53
|
$540.97M | - | 61 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.81
|
$529.35M | 11.2 | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.42
|
$512.39M | - | 46 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$48.13
|
$505.12M | 2.9 | 59 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$93.38
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.18
|
$468.01M | - | 48 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$10.84
|
$463.20M | - | 47 | Compare |
More ENTX Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry